Maintain Hold through FOMC binary; add triggers conditional on breakout confirmation or flush entry levels
All three analysts converge on Hold, which is consistent with the binding 8/20 reflection that caps franchise-quality compression-zone trims at 15-20%. Underweight adds nothing actionable given the FOMC binary proximity (6 sessions) and the intact rising 200 SMA at $190.43, with MS only 12.6% below the 200 SMA at $214. Recent MS Underweight decisions at the calibrated 15-20% trim produced only -0.0% to -0.6% alpha—essentially noise. The Aggressive Analyst's case for adding is tactically wrong given the failed breakout at $230.98, lower highs from $218.38 to $215.35, and the Aggressive Analyst's own admission that "we're not at a confirmed breakout above $219.92 on volume." The Neutral Analyst's FOMC-conditional framework is most calibrated: if Powell pauses or signals hiking cycle end, a confirmed close >$219.92 on volume becomes the breakout-add trigger; if hawkish hold produces a flush, $209 and $204 offer 2:1 reward-to-risk on a range bounce. Hard stop at $199 (below psychological $200 with 1.5x ATR buffer of $4.87). Q3 earnings mid-October remains the structural binary against Q3 2025's $4.61B net income (sequential revenue <$19.5B or EPS <$3.30 confirms deceleration).
| Position | Action |
|---|---|
| Franchise-quality compression-zone trims | capped at 15-20% per 8/20 reflection |
| Pre-catalyst Underweight calls | skip entirely or size even smaller per 9/10 reflection |
| Incremental flush buys on hawkish hold | 2:1 reward-to-risk at $209 (lower BB) and $204 (July swing low) |
Morgan Stanley is a high-quality, earnings-accelerating franchise with 18% ROE, 41.6% operating margins, and 25%+ annual earnings growth trading at a reasonable 17.3x P/E in a constructive macro environment that extends its NII tailwind.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 190.43 | bullish |
| close_50_sma | 215.39 | neutral |
| close_10_ema | 214.62 | bearish |
| rsi | 49.60 | neutral |
| macd / macds / macdh | 0.00 / 0.03 / −0.03 | bearish |
| boll / boll_ub / boll_lb | 214.66 / 219.92 / 209.40 | neutral |
| atr | 4.91 | neutral |
| vwma | 214.67 | neutral |
Support: 209.4 · 190.43 · 200 | Resistance: 219.92 · 215.39 · 214.62
MS remains in a structurally bullish long-term uptrend (price well above 200 SMA at 190.43), but the short- and medium-term picture has deteriorated into a neutral-to-cautious consolidation following the July top at $230.98. MACD has produced a bearish crossover, RSI sits at neutral 49.60, and price is wedged between Bollinger boundaries (209.40–219.92) with the 50 SMA at 215.39 acting as a pivot. Initiating new positions at the 214 area offers poor risk/reward; wait for either a confirmed close above 219.92 to re-engage longs, or capitulation below 209.40 for a better entry. Existing longs should hold with a trailing stop near the 50 SMA/10 EMA zone (~$214).
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Hawkish hold produces flush to $209 (lower Bollinger Band)
Then: Incremental buy for 2:1 reward-to-risk
EV: +20%+ to July highs · concedes: MS trades ~7-8% off all-time highs, making entry not at absolute bottom; MACD shows slight bearish crossover (Histogram: −0.03); Consolidation may persist short-term before resolution
MS is a cyclical franchise at a cyclical peak trading at a fair-to-rich multiple with momentum rolling over; patience is an asset class and a pullback to $195-205 offers 2-3x better risk/reward than buying at $214.
EV: -$5.8% (5.8% downside to $200-202 from $214.38) · concedes: Earnings trajectory is real and Q2 print of $5.58B net income was solid; Capital return story ($5B+ buyback) is credible; MS is not a broken franchise; Base effect from depressed Q2 2025 does explain part of YoY growth; AI tools could eventually deliver productivity gains if properly quantified; 200 SMA at $190 may never be reached
→ vs conservative: Waiting for 200 to 205 entry (5-7% lower) surrenders time, dividend accrual, and exposure to catalysts (GPT-6 Astra, Zacks buy-worthy screen, Cramer 'quiet execution winner' call, Q3 earnings beat setup) in exchange for marginal discount on high-quality compounder with accelerating earnings
→ vs conservative: Overweighting one-day 12.5% pullback from July as trend-defining when stock has consolidated 209-220 range for weeks while fundamental trajectory inflected higher
→ vs conservative: Calling Fed hawkishness and 10-year pushing toward five percent a headwind when higher rates and steeper curves are actually bullish for MS's balance sheet deployment and NII expansion
→ vs neutral: Claiming 50/50 symmetric setup ignores TTM net income 46% growth, tangible book value compounding, five percent capital return yield, and 12.5% above 200 SMA; asymmetry is tilted bullish, not balanced
Market Cap
$336.7B
P/E (TTM)
17.32
Forward P/E
15.71
PEG Ratio
1.89
P/Book
3.16
Beta
1.21
Dividend Yield
2.14%
52-Week High
$232.25
52-Week Low
$151.84
50-Day MA
$215.81
200-Day MA
$191.74
Current Ratio
2.0
Book Value / Share
$67.80
TTM EPS
$12.38
Forward EPS
$13.64
Diluted EPS (2025)
$10.21
Diluted EPS (2024)
$7.95
Q2 2026 EPS
$3.46
Q2 2025 EPS
$2.13
Q1 2026 EPS
$3.43
Profit Margin
25.9%
Operating Margin
41.6%
ROE
18.0%
ROA
1.345%
Revenue TTM
$77.8B
Net Income TTM
$19.5B
Q2 2026 Revenue
$19.88B
Q2 2025 Revenue
$15.60B
Q1 2026 Revenue
$19.32B
Q4 2025 Revenue
$16.76B
Q3 2025 Revenue
$17.08B
Q2 2026 Net Income
$5.58B
Q2 2025 Net Income
$3.54B
Revenue (2025)
$65.97B
Revenue (2024)
$57.62B
Revenue (2023)
$50.67B
Revenue (2022)
$50.21B
Net Income (2025)
$16.86B
Net Income (2024)
$13.39B
Net Income (2023)
$9.09B
Net Income (2022)
$11.03B
Total Assets
$1,675B
Total Assets (2025)
$1,420B
Total Assets (2024)
$1,215B
Total Assets (2023)
$1,194B
Total Assets (2022)
$1,180B
Stockholders' Equity
$116.3B
Stockholders' Equity (2025)
$111.6B
Stockholders' Equity (2024)
$104.5B
Tangible Book Value
$83.6B
Tangible Book Value (2025)
$79.1B
Total Debt
$422.4B
Total Debt (2025)
$370.5B
Long-Term Debt
$391.5B
Current Debt
$30.9B
Net Debt
$299.3B
Cash & Equivalents
$123.0B
Net Loans
$302.4B
Trading Securities
$265.9B
Retained Earnings
$122.8B
Q2 2026 Operating CF
$(2.75)B
Q2 2026 CapEx
$(0.82)B
Q2 2026 Dividends Paid
$(1.68)B
Q2 2026 Buybacks
$(1.67)B
Q2 2026 LT Debt Issued
$43.25B
Debt/Equity Ratio
517%
Revenue Growth (2025 YoY)
14.5%
Net Income Growth (2025 YoY)
25.9%
Q2 2026 Revenue YoY Growth
27.4%
Q2 2026 Net Income YoY Growth
57.7%
Strengths
Concerns
Morgan Stanley delivered a multi-year quarterly high with Q2 2026 revenue of $19.88B (up 27% YoY) and EPS of $3.46, extending five consecutive quarters of net income expansion from $3.54B to $5.58B; full-year 2025 revenue of $65.97B and net income of $16.86B represent 14.5% and 25.9% growth respectively, with TTM earnings of $19.5B implying continued acceleration into 2026. The firm demonstrates best-in-class profitability with a 41.6% operating margin, 25.9% profit margin, and 18.0% ROE, alongside strong capital returns through a 2.14% dividend yield and $1-3B quarterly buybacks. While the balance sheet has expanded substantially (assets up 24% YoY to $1.675T) supporting elevated trading activity and net interest income, the stock trades near technical resistance at $215.81 (50-day MA) and ~7-8% below its 52-week high of $232.25, suggesting the appropriate posture is to maintain exposure on strength and accumulate on any pullbacks toward the 200-day moving average of $191.74.
Macro: Fed hawkish pivot underway with Polymarket pricing 89% probability of at least one rate hike in 2026 (+17.5pp week-over-week), 80% probability by September 2026 (+31pp — sharpest single-week move), and 93% probability of no Fed rate cuts in 2026. August CPI came in firm, pushing 10-year yields to fresh highs just below 5%. US recession odds remain low at 7% for end of 2026. The rate-hike narrative is driven by resilient growth + sticky inflation rather than policy mistake, generally supportive of trading & IB revenues.